The effects of three bioreductive drugs (mitomycin C, RSU-1069 and SR4233) on cell lines selected for their sensitivity to mitomycin C or ionising radiation. by Keohane, A. et al.
Br. J. Cancer (1990), 61, 722 726
© Macmillan
The effects of three bioreductive drugs (mitomycin C, RSU-1069 and
SR4233) on cell lines selected for their sensitivity to mitomycin C or
ionising radiation
A. Keohane, J. Godden, I.J. Stratford & G.E. Adams
MRC Radiobiology Unit, Chilton, Didcot, Oxon. OX]I ORD, UK.
Summary We have investigated the cross-sensitivity of a number of cell lines to three different classes of
bioreductive drugs under both aerobic and hypoxic conditions. The cell lines used were selected for their
sensitivity to DNA-damaging agents and fall into two groups. One group, MMC cells derived from CHO-KI
cells (Robson et al., 1985), show a range of sensitivities to mitomycin C in air. The second group, irs cells were
cloned from V79 Chinese hamster fibroblasts (Jones et al., 1987) and exhibit sensitivity to ionising radiation.
The sensitivity of both groups of cells to mitomycin C (MMC), RSU-1069 and SR4233 was assessed under
aerobic and hypoxic conditions. No difference in aerobic or hypoxic toxicity of MMC was observed for
CHO-KI or MMC sensitive cell lines (MMC-2 and MMC-3). However, the MMC-resistant cell line (MMCT)
was 10 times more sensitive under hypoxic than aerobic conditions. This suggests that MMCF cells lack or are
deficient in the enzymes responsible for activating MMC under aerobic conditions compared to other MMC
cells. In contrast, differential toxicities ofbetween 3 and 30 have been observed for all CHO cells treated with
RSU-1069 and SR4233. Treatment of V79 and irs cells with RSU-1069 and SR4233 also resulted in selective
toxicity towards hypoxic cells. Differential toxicities between 50 and 100 were observed for V79 cells. For both
RSU-1069 and SR4233, the hypoxic toxicities were similar in V79 and irs cells but in air, the radiation
sensitive cells were up to 10 times more sensitive than wild type cells.
Hypoxic cells within tumours are known to limit the efficacy
of radiotherapy. Bioreductive and radiosensitising drugs are
under development in order to improve tumour therapy by
sensitising the hypoxic tumour cells to either radiation or
cytotoxic chemotherapy. One process by which hypoxic cells
can be selectively killed is to utilise the reductive metabolic
pathways which can be exploited readily under poorly oxy-
genated conditions.
The mechanism of action of three different classes of
bioreductive compounds have been investigated in vitro,
using cell lines selected for their sensitivity to DNA damag-
ing agents. The drugs investigated were the bioreductive
quinone antibiotic mitomycin C (Kennedy et al., 1980); a
monofunctional alkylating 2-nitroimidazole RSU-1069
(Adams et al., 1984; Stratford et al., 1986); and the
benzotriazine-di-N-oxide SR4233 (Zeman et al., 1986, 1989).
The cell lines used fall into two groups, both of which were
cloned from Chinese hamster cell lines. The first, MMC cells,
were isolated from Chinese hamster ovary cells, CHO-K1
(Robson et al., 1985), and were either hypersensitive (MMC-
2 and MMC-3), or resistant (MMCl) to mitomycin C. The
concentrations of MMC required to reduce cell survival to
0.37 of the control following 24 hour aerobic exposure (D37
value) have been determined by Robson et al. (1985) and
Hoban et al. (1990) for each cell line. These are: CHO-KI,
0.32; MMC-2, 0.05; MMC-3, 0.07; MMCr, 6.07,UM respec-
tively. The second group of cells, irs cells were originally
cloned from V79 Chinese hamster fibroblasts (Jones et al.,
1987) and exhibit a range of sensitivities to ionising radiation
in air. For these cell lines D37 values (Gy) have been deter-
mined as; V79, 4.2; irs 1, 1.34; irs 2, 1.41; irs 3, 2.06 (Jones et
al., 1987).
The cross-sensitivity of these cell lines to MMC, RSU-1069
and SR4233 has been assessed under both hypoxic and aer-
obic conditions. This type ofstudy may help to determine the
mechanism of action of these agents and the factors
influencing cellular sensitivity to bioreductive cytotoxic drugs,
in particular the enzymes involved in drug activation and
cellular repair pathways.
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Materials and methods
Drugs
RSU-1069 was prepared in this unit by Mr Paul Webb using
the method of Adams et al. (1984). MMC was obtained from
Sigma Chemicals and dissolved in phosphate-buffered saline
immediately before use, to give 2 mg ml-' stock solution.
SR4233 was a gift from Drs J. Martin Brown and Ven
Narayanan (Department of Therapeutic Radiology, Stanford
University, USA and the National Cancer Institute respec-
tively).
Cell culture
MMC mutant cell lines and CHO-Kl cells were maintained
in monolayer cultures using HAM's F12 culture medium
(Gibco) supplemented with 2 mM L-glutamine, penicillin,
streptomycin, 5% new born calf serum and 5% fetal calf
serum (Biological Industries). V79 and irs cells were grown in
monolayer cultures using MEM (Gibco) medium supple-
mented with glutamine, penicillin, streptomycin and 10%
fetal calf serum (Biological Industries). Cultures were incu-
bated at 37°C in a humidified atmosphere of 5% CO2 in air,
and passaged twice weekly.
Drug treatments
Exponentially growing cells were harvested from monolayer
cultures, diluted and appropriate cell numbers plated out in
medium, on glass or plastic Petri dishes for hypoxic or
aerobic drug exposures. Cells were allowed to attach for 2 h
before drug treatment. All drugs were diluted in tissue cul-
ture medium and added to cells for 3 h. For aerobic treat-
ments cells were incubated at 370C for 3 h in an humidified
atmosphere of 5% CO2 in air. For hypoxic exposure drug
was added to the cells on glass Petri dishes and immediately
gassed with N2 + 5% CO2 at 37°C for 3 h. The drug-con-
taining medium was then removed from the dishes, replaced
with fresh medium and cells assayed 7-10 days later for
colony formation.
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Results
MMC cells
These cell lines have been isolated on the basis of their
sensitivity or resistance to mitomycin C following aerobic
exposure to the drug. Each mutant cell line and the wild type
CHO-KI cells were treated with MMC, RSU-1069 and
SR4233 under both aerobic and hypoxic conditions to assess
their cross-sensitivities to other bioreductive drugs.
Mitomycin C Figure 1 shows the survival curves from
CHO-Ki and the MMC cell lines MMC-2 and MMC-3
following 3 h aerobic or hypoxic exposure to MMC. In each
of the three cell lines the drug was slightly more toxic in
hypoxic cells compared to the effect in aerobic cells but the
differential toxicities were small: 1.1 for CHO-KI, 1.5 for
MMC-2 and 1.2 for MMC-3 cell lines. (Differential toxicity
is defined as the ratio of the concentrations of drug required
to reduce cell survival to 10% under aerobic and hypoxic
conditions.) Under aerobic conditions MMC' cells were 20
times more resistant to MMC than the parent cell line but
only two-fold resistant under hypoxic conditions (Table I).
These data suggest that the MMC' cells differ in the way they
metabolise MMC compared to the other cell lines. Further-
more the difference in hypoxic sensitivity of the wild type and
MMCT cells is small compared to the difference observed in
air which suggests that differences between the two cell lines
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Table I Differential toxicities and drug concentrations required to
reduce CHO-KI and MMC-cell survival to 10% following exposure
to bioreductive drugs
Aerobic Hypoxic Differential
Cell line Drug exposure exposure toxicity
CHO-KI MMC (PM) 2.9 2.7 1.1
MMC-2 2.3 1.5 1.5
MMC-3 1.2 1.0 1.2
MMCr 53 5.3 10.0
CHO-KI RSU-1069 (mM) 0.49 0.098 5.0
MMC-2 0.20 0.037 5.4
MMC-3 0.47 0.11 4.3
MMCr 0.55 0.12 4.5
CHO-Ki SR4233 (mM) 0.33 0.012 28
MMC-2 0.28 0.013 22
MMC-3 0.25 0.017 15
MMCr 0.50 0.024 21
may lie in the ability to activate MMC under aerobic condi-
tions. The observation that both MMC-2 and MMC-3 cell
lines are more sensitive to MMC compared to CHO-K1,
under both aerobic and hypoxic conditions suggests that the
oxygenation status is not important for the enhanced sen-
sitivity.
RSU-1069 The cross-sensitivity of MMC cells to RSU-1069
was also investigated. Survival curves revealed a pattern
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Figure I Survival curves for CHO-KI and MMC cells following 3 h exposure to MMC under aerobic (0) or hypoxic (0)
conditions. Points represent data pooled from three experiments.724 A. KEOHANE et al.
different to that observed with MMC. The sensitivities of
MMC-3 and MMCT cells to RSU-1069 were similar to that
of CHO-Ki wild type under both aerobic and hypoxic condi-
tions. However, MMC-2 cells were 2-3 times more sensitive
than CHO-Kl cells in air and nitrogen. Differential toxicities
of about 5 (Table I) were observed for CHO-Ki and mito-
mycin C sensitive or resistant cells alike. Since the MMCT
cells were not resistant to RSU-1069 under aerobic condi-
tions, it seems likely that this class of compound is activated
into a cytotoxic state by a different pathway to that of
MMC.
SR4233 Each cell line was considerably more sensitive to
SR4233 under hypoxic conditions than in oxygen. The
differential toxicities were between 15 (MMC-3) and 28
(CHO-KI) (Table I). The MMC-sensitive cell lines (MMC-2
and MMC-3) both showed sensitivities similar to that of
CHO-Kl cells under both aerobic and hypoxic conditions
(Table I). However, it is notable that MMCF cells were twice
as resistant as the CHO-KI cells to SR4233 under both
exposure conditions. Results from the experiments in which
MMC cells were treated with other classes of bioreductive
compound suggest that each drug is metabolised differently.
However, a slight aerobic cross-resistance (<2) has been
observed in MMCT cells following exposure to SR4233. This
was not as large as that which has been observed following
treatment with MMC but may indicate that there is a step
common to the metabolism of both drugs in these cells.
irs cells
In a parallel study three cell lines sensitive to ionising radia-
tion and the V79 wild type were also treated with MMC,
RSU-1069 and SR4233. irs 1 and irs 2 are about three times
more sensitive and irs 3 twice as sensitive to X-rays compared
to V79 cells (Jones et al., 1987). These cell lines also have
variable sensitivities to other DNA damaging agents, for
example UV irradiation, EMS and mitomycin C (Jones et al.,
1987). Jones et al. (1987) have shown that irs 1 cells were
60-fold more sensitive to MMC following a 2 h exposure
under aerobic conditions compared to the parent cell line,
and also showed the greatest sensitivities to UV and EMS.
irs 2 and irs 3 were more sensitive than V79 to each agent but
the differences were small compared to those observed for
irs 1.
Mitomycin C In the present study irs 1 was found to be at
least 25 times more sensitive to MMC (following a 3 h
exposure under aerobic conditions) than V79 cells (Table II).
irs 2 cells were less sensitive and irs 3 equally as sensitive as
the parent cells in air, but MMC was more toxic to all cell
lines exposed under anaerobic conditions. However, apart
from irs 2 the differential toxicities observed were small
(Table II). irs2 cells have a differential toxicity of 8, four
times greater than that of V79 cells. This increased differ-
ential is mainly due to the relative resistance of these cells to
Table II Differential toxicities and drug concentrations required to
reduce V79 and irs cell survival to 10% following exposure to
bioreductive drugs
Aerobic Hypoxic Differential
Cell line Drug exposure exposure toxicity
V79 MMC (PM) 2.1 1.0 2.1
irsi 0.085 0.068 1.2
irs 2 5.8 0.73 8.0
irs 3 2.2 0.85 2.5
V79 RSU-1069 (mM) 0.75 0.015 50
irs 1 0.075 0.0075 10
irs 2 0.39 0.014 27
irs 3 0.20 0.01 20
V79 SR4233 (mM) 0.30 0.005 60
irs 1 0.02 0.0028 7.2
irs 2 0.065 0.0027 23.0
irs3 0.05 0.0026 19
MMC under aerobic conditions, compared with the sensiti-
vities of the other cell lines. irs2 are also slightly more
sensitive than V79 cells following hypoxic exposure. There
does not appear to be any correlation between X-ray sen-
sitivity and sensitivity to MMC for the irs cell lines.
RSU-1069 A different pattern of cell survival has been
observed following treatment of irs cells with RSU-1069.
Figure 2 shows that RSU-1069 is preferentially toxic to
hypoxic cells in all four cell lines. V79 cells show a
differential toxicity of 50 but this value is reduced to 26 and
20 for irs 2 and irs 3 respectively. irs 1 cells have a differential
toxicity of only 10 (Table II). This is because irs I are 10
times more sensitive than V79 under aerobic conditions
although both lines show similar hypoxic response.
Comparison of the survival curves for irs and V79 cells
treated wtih RSU-1069 under either aerobic or hypoxic con-
ditions, reveals that all lines show similar sensitivities to the
drug under hypoxic conditions. However, under aerobic con-
ditions irs cells were between 2 and 10 times as sensitive to
RSU-1069 as V79 wild type cells.
SR4233 Figure 3 compares the aerobic and hypoxic sur-
vival curves of irs cells treated with SR4233. A differential
toxicity of 60 calculated for V79 cells is reduced to between
23 and 7.2 for the radiation sensitive cell lines (Table II). All
cell lines were more sensitive when exposed to SR4233 in
anoxia but as was observed for RSU-1069 (Figure 2), the
hypoxic survival curves of irs cells were very similar to that
observed for V79 cells. The reduction in differential toxicity
is again due therefore, to differences in the aerobic toxicities
of the irs compared to V79 cells, where irs cells were up to 15
times more sensitive.
The results described above show that there is little
difference in the sensitivity of the mutant and wild type cells
to either RSU-1069 or SR4233 under hypoxic conditions.
Furthermore these data suggest that the irs cells have not lost
their capacity to reduce and activate the compounds under
hypoxic conditions.
Discussion
The ultimate biological effects of DNA damage induced
either chemically or by radiation depend on a variety of
factors of which potential for repair may be the most
significant. A comparison of the response to DNA damage in
cells selected for their sensitivity to different genotoxic agents
should give some insight not only to the nature of the
sensitivity but also the mode of action by which these geno-
toxic agents kill cells.
The CHO cells were selected for this study on the basis of
their different sensitivities to MMC in air. These cells do not
show any patterns of cross-resistance or sensitivity towards
RSU-1069 or SR4233 in air, although MMC-2 cells show a
small increase in sensitivity to RSU-1069 and MMCI cells are
slightly more resistant to SR4233 than the parent cell lines.
Under aerobic conditions the MMC' cells are at least 20
fold resistant to MMC compared to the CHO-KI cells, but
this resistance is almost completely overcome under hypoxic
conditions (Hoban et al., 1990). This results in a differential
toxicity of 10 for this cell line following exposure to MMC.
In contrast, there is only a slight increase in the toxicity of
MMC in the other cell lines in nitrogen. This suggests that
the CHO cell lines with the exception of MMCr cells can
activate MMC almost equally well under aerobic and hy-
poxic conditions. It is only under conditions of low oxygena-
tion that MMC' cells have the ability to reduce and thereby
activate MMC.
Support for this proposal comes from the recent studies of
Hoban et al. (1990) on the levels ofvarious enzymes in CHO
cells that are capable of activating MMC. Both the CHO-KI
and MMCr cells lack measurable DT-diaphorase activity but,
in particular, the MMCT cells show a 3-4-fold lower level ofEFFECTS OF THREE BIOREDUCTIVE DRUGS 725
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Figure 2 Survival curves for V79 and irs cells following 3 h exposure to RSU-1069 under aerobic (0) or hypoxic (@) conditions.
Each point represents the mean of data from three experiments and error bars (s.e.m.) are included where they exceed the size of
the symbol used.
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Figure 3 Survival curves for V79 and irs cells following 3 h
exposure to SR4233 under aerobic (open symbols) or hypoxic
(closed symbols) conditions. 00, V79; A A, irs 1; O-, irs2;
O*, irs3.
NADPH cytochrome P450 reductase compared to the CHO-
Kl cells. Both these enzymes have been implicated in the
bio-activation of MMC (Keyes et al., 1984; Schlager &
Powis, 1988; Marshall et al., 1989; Dulhanty et al., 1989) and
it is this P450 enzyme that is considered to be important for
activation of MMC in the CHO cells (Hoban et al., 1990).
Thus, the lower level of P450 reductase in the MMCr cells
may be insufficient to allow activation of the drug in air but
not under hypoxic conditions.
The values of differential toxicity for RSU-1069 are about
5 for each of the CHO cell lines. It is known that NADPH
cytochrome P450 reductase plays an important part in the
reductive activation of the 2-nitromidazole, benznidazole
(Walton et al., 1989). Presumably this enzyme would also be
important for activation of RSU-1069. However, the
differences in enzyme levels between the MMCI and CHO-KI
cells do not lead to significant differences in toxicity for this
drug. Similarly, there is little difference in the absolute tox-
icity of SR4233 in either air or N2 for these cell lines,
although this drug is known to be metabolised primarily by
cytochrome P450 in microsomal preparations (Walton et al.,
1989).
The irs cells are known to belong to different genetic
complementation groups. Therefore the radiosensitivity of
each cell line may reflect a mutation, inactivation or deletion
of a different gene(s) in each case, although they may be
related. These lines are known to express a range of sen-
sitivities to other genotoxic agents (Jones et al., 1987). The
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present results show that they also exhibit variable sen-
sitivities to three classes of bioreductive compound. Both V79
cells and radiation-sensitive cell lines are more sensitive to all
three drugs under hypoxic conditions compared to air. irs I
cells are much more sensitive to MMC under both aerobic
and hypoxic conditions compared to V79 cells. In contrast,
we have found that irs 2 cells show MMC toxicity equivalent
to that of V79 cells under nitrogen but appear to be 2-fold
resistant in air. As discussed for the MMC' cells, this may
indicate that irs 2 cells are either unable to activate MMC
adequately in air, or may possess a repair mechanism capable
of repairing or protecting against the damage produced by
MMC in the presence of oxygen.
Treatment of irs cell lines with RSU-1069 and SR4233 has
shown that each of the mutant cell lines is considerably more
susceptible to the aerobically induced drug damage than are
V79 cells. Each line (V79 and irs) are equally sensitive to
these two drugs under anoxia compared to the range of
sensitivities shown in air. For each drug, the mechanism of
cytotoxic action is different in aerobic cells compared with
that in hypoxic cells. For example, RSU-1069 is known to
act as a monofunctional agent in air but is converted to a
bifunctional reacting species when the compound is reduced
under poorly oxygenated conditions (Stratford et al., 1986).
The different aerobic responses of these cell lines to the drugs
suggest that in air they have a reduced capacity to cope with
the drug-induced damage compared to that of V79 cells. One
possibility is that the irs cells lack a DNA repair facility
normally present in V79 cells such that doses which are not
toxic in wild type V79 cells become lethal in the mutant cell
lines. It has been demonstrated, however (Thacker & Gan-
esh, 1990), that none of the irs cell lines are deficient in the
mechanism necessary for the rejoining of single or double
strand DNA breaks following y-irradiation.
The irs cells are radiation sensitive and it is known that a
substantial proportion of damage caused by radiation is
oxidative, i.e. involving OH radicals. The superoxide radical,
02-, is formed as a consequence of futile one-electron reduc-
tion of bioreductive drugs in the presence of oxygen (Mason
& Holtzman, 1975; Wardman & Clarke, 1976; Kirkpatrick,
1989). The radical can, under appropriate conditions, lead to
the formation of the -OH radical. Therefore cellular sen-
sitivity to oxidative damage could provide an explanation for
the sensitivity of the irs cells to RSU-1069 and SR4233 in air
as well as their radiation sensitivity. This proposal is cur-
rently being evaluated.
Mechanisms involving drug transport, drug activation,
drug detoxification and the elimination of, or repair of, drug
induced lesions may each influence the levels of drug sen-
sitivity observed in the mutant cell lines. The present results
show that under hypoxia differences in the efficiency of any
of these processes are unimportant in irs cells since the
cytotoxicities are fairly constant. This appears not to be so
for aerobic cells. Further studies are necessary in order to
identify which of these processes are affected in the mutant
cell lines. It is clear however that the variability in the
*radiation sensitivities of these lines is not related to their
abilities to metabolically reduce, or activate the drugs under
hypoxic conditions.
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